# BG9928 in Subjects With Hepatic Impairment

> **NCT00858156** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 23 (actual)

## Conditions studied

- Hepatic Impairment

## Interventions

- **DRUG:** BG9928

## Key facts

- **NCT ID:** NCT00858156
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2010-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00858156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00858156, "BG9928 in Subjects With Hepatic Impairment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00858156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*